Galmed Pharmaceuticals Ltd (GLMD)
0.3706
-0.01
(-2.14%)
USD |
NASDAQ |
Apr 19, 16:00
0.365
-0.01
(-1.51%)
After-Hours: 20:00
Galmed Pharmaceuticals Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | 17.37M |
| September 30, 2021 | 17.37M |
| June 30, 2021 | 18.08M |
| March 31, 2021 | 18.08M |
| December 31, 2020 | 0.768M |
| September 30, 2020 | 0.816M |
| June 30, 2020 | 0.109M |
| March 31, 2020 | 0.13M |
| December 31, 2019 | 0.143M |
| September 30, 2019 | 0.21M |
| June 30, 2019 | 0.227M |
| March 31, 2019 | 80.24M |
| December 31, 2018 | 80.18M |
| September 30, 2018 | 92.64M |
| June 30, 2018 | 95.34M |
| March 31, 2018 | 15.56M |
| December 31, 2017 | 15.55M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.968M |
| June 30, 2017 | 5.113M |
| March 31, 2017 | 4.734M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 41.86M |
| September 30, 2014 | 42.65M |
| June 30, 2014 | 43.82M |
| March 31, 2014 | 43.82M |
| December 31, 2013 | 1.94M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.109M
Minimum
Jun 2020
18.08M
Maximum
Mar 2021
6.663M
Average
0.768M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
| Compugen Ltd | -- |
| Pluri Inc | -- |
| BioLine Rx Ltd | 15.06M |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | 2.899M |